{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:06:45Z","timestamp":1790770005229,"version":"4.1.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.01226","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T11:44:36Z","timestamp":1595591076000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Deregulation of Polycomb Repressive Complex-2 in Mantle Cell Lymphoma Confers Growth Advantage by Epigenetic Suppression of cdkn2b"],"prefix":"10.3389","volume":"10","author":[{"given":"Christos","family":"Demosthenous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy P.","family":"Troska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e987","DOI":"10.1097\/MD.0000000000000987","article-title":"Prevalence of common non-hodgkin lymphomas and subtypes of hodgkin lymphoma by nodal site of involvement: a systematic retrospective review of 938 cases","volume":"94","author":"Laurent","year":"2015","journal-title":"Medicine."},{"key":"B3","doi-asserted-by":"publisher","first-page":"E109","DOI":"10.1016\/S2352-3026(18)30018-8","article-title":"Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial","volume":"5","author":"Jerkeman","year":"2018","journal-title":"Lancet Haematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/bjh.14870","article-title":"Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies","volume":"179","author":"Rule","year":"2017","journal-title":"Brit J Haematol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09784","article-title":"The polycomb complex PRC2 and its mark in life","volume":"469","author":"Margueron","year":"2011","journal-title":"Nature."},{"key":"B6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molcel.2004.06.020","article-title":"SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex","volume":"15","author":"Cao","year":"2004","journal-title":"Mol Cell."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6857","DOI":"10.1128\/MCB.25.16.6857-6868.2005","article-title":"Subunit contributions to histone methyltransferase activities of fly and worm polycomb group complexes","volume":"25","author":"Ketel","year":"2005","journal-title":"Mol Cell Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/sj.embor.7400376","article-title":"Nucleosome binding and histone methyltransferase activity of drosophila PRC2","volume":"6","author":"Nekrasov","year":"2005","journal-title":"EMBO Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1038\/sj.emboj.7600402","article-title":"Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity","volume":"23","author":"Pasini","year":"2004","journal-title":"Embo J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1126\/science.1165395","article-title":"Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer","volume":"322","author":"Varambally","year":"2008","journal-title":"Science."},{"key":"B11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature."},{"key":"B12","doi-asserted-by":"publisher","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells","volume":"100","author":"Kleer","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1186\/1471-2407-10-524","article-title":"Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma","volume":"10","author":"Wagener","year":"2010","journal-title":"BMC Cancer."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/j.1349-7006.2011.01958.x","article-title":"Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker","volume":"102","author":"Takawa","year":"2011","journal-title":"Cancer Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/leu.2010.311","article-title":"EZH2 Y641 mutations in follicular lymphoma","volume":"25","author":"Bodor","year":"2011","journal-title":"Leukemia."},{"key":"B16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1182\/blood-2013-04-496893","article-title":"EZH2 mutations are frequent and represent an early event in follicular lymphoma","volume":"122","author":"Bodor","year":"2013","journal-title":"Blood."},{"key":"B18","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Bea","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41417-018-0022-5","article-title":"Genomic landscape and prognostic analysis of mantle cell lymphoma","volume":"25","author":"Yang","year":"2018","journal-title":"Cancer Gene Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/leu.2016.175","article-title":"Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma","volume":"31","author":"Bouska","year":"2017","journal-title":"Leukemia."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13045-019-0814-6","article-title":"EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications","volume":"12","author":"Li","year":"2019","journal-title":"J Hematol Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"80223","DOI":"10.18632\/oncotarget.17956","article-title":"Long non-coding RNA profile in mantle cell lymphoma identifies a functional lncRNA ROR1-AS1 associated with EZH2\/PRC2 complex","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget."},{"key":"B24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11899-018-0466-6","article-title":"Emerging EZH2 Inhibitors and their application in lymphoma","volume":"13","author":"Lue","year":"2018","journal-title":"Curr Hematol Malig Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","article-title":"EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation","volume":"23","author":"Beguelin","year":"2013","journal-title":"Cancer Cell."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e107016","DOI":"10.1371\/journal.pone.0107016","article-title":"The long non-coding RNA GAS5 cooperates with the eukaryotic translation initiation factor 4E to regulate c-Myc translation","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS ONE."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1182\/blood-2009-05-220889","article-title":"Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting akt signaling through mTORC2","volume":"114","author":"Gupta","year":"2009","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/leu.2013.251","article-title":"Epigenetic mechanisms of protein tyrosine phosphatase 6 suppression in diffuse large B-cell lymphoma: implications for epigenetic therapy","volume":"28","author":"Witzig","year":"2014","journal-title":"Leukemia."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"9488","DOI":"10.18632\/oncotarget.3378","article-title":"Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma","volume":"6","author":"Demosthenous","year":"2015","journal-title":"Oncotarget."},{"key":"B31","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nrc1991","article-title":"Polycomb silencers control cell fate, development and cancer","volume":"6","author":"Sparmann","year":"2006","journal-title":"Nat Rev Cancer."},{"key":"B32","doi-asserted-by":"publisher","first-page":"20980","DOI":"10.1073\/pnas.1012525107","article-title":"Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas","volume":"107","author":"Sneeringer","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1182\/blood-2010-11-321208","article-title":"Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation","volume":"117","author":"Yap","year":"2011","journal-title":"Blood."},{"key":"B34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature."},{"key":"B35","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature08398","article-title":"Role of the polycomb protein EED in the propagation of repressive histone marks","volume":"461","author":"Margueron","year":"2009","journal-title":"Nature."},{"key":"B36","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nchembio.1084","article-title":"A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells","volume":"8","author":"Knutson","year":"2012","journal-title":"Nat Chem Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/gcc.20277","article-title":"Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma","volume":"45","author":"Hutter","year":"2006","journal-title":"Genes Chromosomes Cancer."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.humpath.2007.05.009","article-title":"Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma","volume":"38","author":"Chim","year":"2007","journal-title":"Hum Pathol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"930","DOI":"10.2353\/ajpath.2010.090769","article-title":"Deregulated expression of the polycomb-group protein SUZ12 target genes characterizes mantle cell lymphoma","volume":"177","author":"Martin-Perez","year":"2010","journal-title":"Am J Pathol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/modpathol.2016.114","article-title":"Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1\/2 and MYC in aggressive B-cell lymphomas","volume":"29","author":"Tian","year":"2016","journal-title":"Modern Pathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.beha.2018.07.005","article-title":"Evolving treatment strategies in mantle cell lymphoma","volume":"31","author":"Edwin","year":"2018","journal-title":"Best Pract Res Clin Haematol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1101\/gad.1524107","article-title":"Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells","volume":"21","author":"Tan","year":"2007","journal-title":"Genes Dev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1021\/ml3003346","article-title":"Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2","volume":"3","author":"Verma","year":"2012","journal-title":"ACS Med Chem Lett."},{"key":"B44","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.ccr.2012.09.003","article-title":"Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas","volume":"22","author":"Zhang","year":"2012","journal-title":"Cancer Cell."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1182\/blood-2009-12-257485","article-title":"Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma","volume":"116","author":"Leshchenko","year":"2010","journal-title":"Blood."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1182\/blood-2009-07-233858","article-title":"Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML","volume":"115","author":"Paul","year":"2010","journal-title":"Blood."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01226\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T11:44:39Z","timestamp":1595591079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01226\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":46,"alternative-id":["10.3389\/fonc.2020.01226"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.01226","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,24]]},"article-number":"1226"}}